Confronta i metodi

	Test di Fagerström per la Dipendenza da Nicotina	Patient Health Questionnaire-2
Campo	Servizi sanitari	Servizi sanitari
Famiglia	Process / pipeline	Process / pipeline
Anno di origine	1991	2003
Ideatore	Karl O. Fagerstrom	Kurt Kroenke, Robert L. Spitzer, and Janet B. Williams
Tipo	Six-item nicotine dependence screening	Two-item depression screening instrument
Fonte seminale	Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86(9), 1119-1127.	Kroenke, K., Spitzer, R. L., & Williams, J. B. (2003). The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care, 41(11), 1284-1292.
Alias	FTND, Fagerstrom Test	PHQ-2, Patient Health Questionnaire
Correlati	3	3
Sintesi	The Fagerström Test for Nicotine Dependence (FTND) is a brief, validated self-report instrument originally developed by Fagerstrom in 1978 and revised by Heatherton and colleagues in 1991 to quantify the severity of nicotine dependence in cigarette smokers. The FTND comprises six items assessing morning cigarette use, daily cigarette consumption, and the subjective difficulty of abstaining from smoking. It is the most widely used measure of nicotine dependence in smoking cessation research and clinical practice.	The Patient Health Questionnaire-2 (PHQ-2) is an ultra-brief, validated two-item screening instrument developed by Kroenke and colleagues in 2003 to identify major depression in primary care and medical populations. The PHQ-2 assesses the two cardinal symptoms of depression (depressed mood and anhedonia) over the past two weeks using a 0-3 frequency scale. It is the shortest validated depression screening tool enabling routine use in time-constrained clinical settings.